110 related articles for article (PubMed ID: 2195576)
1. Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
Kravitz HM; Fogg L; Fawcett J; Edwards J
Psychiatry Res; 1990 May; 32(2):141-9. PubMed ID: 2195576
[TBL] [Abstract][Full Text] [Related]
2. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
Remick RA; Keller FD; Buchanan RA; Gibson RE; Fleming JA
Can J Psychiatry; 1988 Oct; 33(7):590-4. PubMed ID: 3058290
[TBL] [Abstract][Full Text] [Related]
4. Challenging the amphetamine challenge test: report of an antidepressant treatment study.
Kravitz HM; Edwards JH; Fawcett J; Fogg L
J Affect Disord; 1990 Oct; 20(2):121-8. PubMed ID: 2148326
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the safety and efficacy of alprazolam and desipramine in moderately severe depression.
Remick RA; Fleming JA; Buchanan RA; Keller FD; Hamilton P; Loomer F; Miles JE
Can J Psychiatry; 1985 Dec; 30(8):597-601. PubMed ID: 4084899
[TBL] [Abstract][Full Text] [Related]
6. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Rosenberg R; Bech P; Mellergård M; Ottosson JO
Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
[TBL] [Abstract][Full Text] [Related]
7. Rapid relief of anxiety in cancer patients with both alprazolam and placebo.
Wald TG; Kathol RG; Noyes R; Carroll BT; Clamon GH
Psychosomatics; 1993; 34(4):324-32. PubMed ID: 8351307
[TBL] [Abstract][Full Text] [Related]
8. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
10. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Pecknold JC; Swinson RP; Kuch K; Lewis CP
Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Jonas JM; Cohon MS
J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
[TBL] [Abstract][Full Text] [Related]
12. Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
Cowley DS; Dager SR; Roy-Byrne PP; Avery DH; Dunner DL
Biol Psychiatry; 1991 Jul; 30(1):49-56. PubMed ID: 1892962
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of a beta-adrenergic antagonist and a tricyclic antidepressant: a pilot study.
Tang SW; Remington G; Persad E; Rosenblat R
Psychiatry Res; 1990 Aug; 33(2):101-6. PubMed ID: 2243886
[TBL] [Abstract][Full Text] [Related]
14. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders.
Maier W; Buller R; Philipp M; Heuser I
J Affect Disord; 1988; 14(1):61-8. PubMed ID: 2963053
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine and desipramine in major depressive disorder.
Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
[TBL] [Abstract][Full Text] [Related]
16. Comparison of alprazolam and imipramine for treatment of outpatient depression.
Overall JE; Biggs J; Jacobs M; Holden K
J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared.
Ward N; Bokan JA; Phillips M; Benedetti C; Butler S; Spengler D
J Clin Psychiatry; 1984 Mar; 45(3 Pt 2):54-9. PubMed ID: 6321455
[TBL] [Abstract][Full Text] [Related]
18. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Dawson GW; Jue SG; Brogden RN
Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
[TBL] [Abstract][Full Text] [Related]
19. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
Enkelmann R
Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
[TBL] [Abstract][Full Text] [Related]
20. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
